HomeCompareRACB vs DIVO

RACB vs DIVO: Dividend Comparison 2026

RACB yields 19.79% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RACB wins by $41.4K in total portfolio value
10 years
RACB
RACB
● Live price
19.79%
Share price
$10.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.1K
Annual income
$6,590.73
Full RACB calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — RACB vs DIVO

📍 RACB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRACBDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RACB + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RACB pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RACB
Annual income on $10K today (after 15% tax)
$1,682.34/yr
After 10yr DRIP, annual income (after tax)
$5,602.12/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, RACB beats the other by $4,767.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RACB + DIVO for your $10,000?

RACB: 50%DIVO: 50%
100% DIVO50/50100% RACB
Portfolio after 10yr
$51.4K
Annual income
$3,786.21/yr
Blended yield
7.37%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RACB buys
0
DIVO buys
0
No recent congressional trades found for RACB or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRACBDIVO
Forward yield19.79%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$72.1K$30.7K
Annual income after 10y$6,590.73$981.68
Total dividends collected$40.8K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RACB vs DIVO ($10,000, DRIP)

YearRACB PortfolioRACB Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$12,679$1,979.22$11,349$649.42+$1.3KRACB
2$15,912$2,345.32$12,833$688.83+$3.1KRACB
3$19,777$2,750.76$14,459$727.90+$5.3KRACB
4$24,356$3,195.19$16,238$766.49+$8.1KRACB
5$29,739$3,677.64$18,179$804.47+$11.6KRACB
6$36,017$4,196.61$20,293$841.71+$15.7KRACB
7$43,288$4,750.07$22,591$878.14+$20.7KRACB
8$51,654$5,335.55$25,087$913.65+$26.6KRACB
9$61,220$5,950.16$27,791$948.18+$33.4KRACB
10$72,096$6,590.73$30,718$981.68+$41.4KRACB

RACB vs DIVO: Complete Analysis 2026

RACBStock

Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.

Full RACB Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this RACB vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RACB vs SCHDRACB vs JEPIRACB vs ORACB vs KORACB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.